Advancing cancer care and equity through telehealth, communication science, and behavioral economics

通过远程医疗、传播科学和行为经济学促进癌症护理和公平

基本信息

  • 批准号:
    10453882
  • 负责人:
  • 金额:
    $ 113.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2027-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT (OVERALL) The University of Pennsylvania Telehealth Research Center in Cancer Care (Penn TRC) will apply insights from communication science and behavioral economics to design and test innovative telehealth strategies to improve effectiveness and equity across the cancer care continuum, with an emphasis on understanding mechanisms of action. The COVID-19 pandemic led to dramatic growth in the use of telehealth for cancer care delivery, fostered by both clinical need and temporary waivers. Telehealth strategies have included both synchronous communication (real-time video or telephone conferencing) and asynchronous communication (sequential health information exchange through text messaging or secure portals). Yet, fundamental knowledge gaps include the extent to which telehealth may be superior to non-telehealth care delivery strategies for access, quality, and outcomes; how telehealth may enhance or detract from achieving health equity in cancer care in the context of the digital divide and persistent cancer disparities; and the impact of telehealth on health care efficiency. The Penn TRC will address an overarching research theme: to apply insights from communication science and behavioral economics to design and test synchronous telehealth strategies, supported by asynchronous elements, to improve access, quality, outcomes, equity, and efficiency across the cancer care continuum. We focus on lung cancer as a model for telehealth across the care continuum, from screening to treatment to survivorship. We bring together a team of international experts in communication science, behavioral economics, cancer care delivery, telehealth, health care innovation, mixed methods, and health equity to achieve the following specific aims: 1) Apply concepts, strategies, tools, and methods from communication science and behavioral economics to design and test synchronous telehealth strategies, supported by asynchronous elements, to improve access, quality, outcomes, equity, and efficiency for patients across the care continuum; 2) Conduct a pragmatic randomized clinical trial to compare the effectiveness of telehealth strategies to increase shared decision making for lung cancer screening using a Sequential Multiple Assignment Randomized Trial (SMART) design; 3) Conduct two rapid-cycle pilot projects, with methods and measures aligned with the pragmatic trial, to design and test the effectiveness of telehealth to improve cancer care, identify multilevel mechanisms of action, and lay the foundation for future, more definitive pragmatic trials; and 4) Build capacity to advance a national telehealth research agenda and train the next generation of investigators with expertise in cancer care, telehealth and health equity. By joining together interdisciplinary faculty across Penn, the Penn TRC will result in novel, scalable, and generalizable disseminated strategies to drive lasting improvements in cancer care and health equity. Penn has an unparalleled environment in which to bring together these areas of study.
项目摘要/摘要(总体)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Justin Bekelman其他文献

Justin Bekelman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Justin Bekelman', 18)}}的其他基金

Admin_Core
管理核心
  • 批准号:
    10663327
  • 财政年份:
    2022
  • 资助金额:
    $ 113.75万
  • 项目类别:
Advancing cancer care and equity through telehealth, communication science, and behavioral economics
通过远程医疗、传播科学和行为经济学促进癌症护理和公平
  • 批准号:
    10663326
  • 财政年份:
    2022
  • 资助金额:
    $ 113.75万
  • 项目类别:
Admin_Core
管理核心
  • 批准号:
    10453883
  • 财政年份:
    2022
  • 资助金额:
    $ 113.75万
  • 项目类别:
Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer
乳腺癌放射治疗的心脏毒性标志物
  • 批准号:
    10401906
  • 财政年份:
    2020
  • 资助金额:
    $ 113.75万
  • 项目类别:
Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer
乳腺癌放射治疗的心脏毒性标志物
  • 批准号:
    10249141
  • 财政年份:
    2020
  • 资助金额:
    $ 113.75万
  • 项目类别:
Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer
乳腺癌放射治疗的心脏毒性标志物
  • 批准号:
    10613352
  • 财政年份:
    2020
  • 资助金额:
    $ 113.75万
  • 项目类别:
Effectiveness of Radiotherapy for Prostate Cancer
前列腺癌放射治疗的有效性
  • 批准号:
    8701251
  • 财政年份:
    2012
  • 资助金额:
    $ 113.75万
  • 项目类别:
Effectiveness of Radiotherapy for Prostate Cancer
前列腺癌放射治疗的有效性
  • 批准号:
    8383228
  • 财政年份:
    2012
  • 资助金额:
    $ 113.75万
  • 项目类别:
Effectiveness of Radiotherapy for Prostate Cancer
前列腺癌放射治疗的有效性
  • 批准号:
    8899458
  • 财政年份:
    2012
  • 资助金额:
    $ 113.75万
  • 项目类别:
Effectiveness of Radiotherapy for Prostate Cancer
前列腺癌放射治疗的有效性
  • 批准号:
    8532663
  • 财政年份:
    2012
  • 资助金额:
    $ 113.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了